Natera Total Assets 2014-2024 | NTRA
Natera total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Natera total assets for the quarter ending September 30, 2024 were $1.591B, a 9.98% increase year-over-year.
- Natera total assets for 2023 were $1.442B, a 3.39% increase from 2022.
- Natera total assets for 2022 were $1.394B, a 12.78% increase from 2021.
- Natera total assets for 2021 were $1.236B, a 32.65% increase from 2020.
| Natera Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $1,442 |
| 2022 | $1,394 |
| 2021 | $1,236 |
| 2020 | $932 |
| 2019 | $583 |
| 2018 | $268 |
| 2017 | $215 |
| 2016 | $211 |
| 2015 | $265 |
| 2014 | $124 |
| 2013 | $60 |
| Natera Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,591 |
| 2024-06-30 | $1,517 |
| 2024-03-31 | $1,468 |
| 2023-12-31 | $1,442 |
| 2023-09-30 | $1,447 |
| 2023-06-30 | $1,248 |
| 2023-03-31 | $1,319 |
| 2022-12-31 | $1,394 |
| 2022-09-30 | $1,009 |
| 2022-06-30 | $1,067 |
| 2022-03-31 | $1,145 |
| 2021-12-31 | $1,236 |
| 2021-09-30 | $1,311 |
| 2021-06-30 | $850 |
| 2021-03-31 | $894 |
| 2020-12-31 | $932 |
| 2020-09-30 | $977 |
| 2020-06-30 | $723 |
| 2020-03-31 | $559 |
| 2019-12-31 | $583 |
| 2019-09-30 | $380 |
| 2019-06-30 | $383 |
| 2019-03-31 | $261 |
| 2018-12-31 | $268 |
| 2018-09-30 | $277 |
| 2018-06-30 | $194 |
| 2018-03-31 | $219 |
| 2017-12-31 | $215 |
| 2017-09-30 | $204 |
| 2017-06-30 | $158 |
| 2017-03-31 | $176 |
| 2016-12-31 | $211 |
| 2016-09-30 | $242 |
| 2016-06-30 | $261 |
| 2016-03-31 | $266 |
| 2015-12-31 | $265 |
| 2015-09-30 | $262 |
| 2015-06-30 | $107 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.908B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |